Nordics Oncology

Oncology Careers at
​​​​​​​MSD Nordics

Do you dream of a career dedicated to extending and improving the lives of cancer patients? Our development programme in Immuno-Oncology aim to improve life for cancer patients and their families. When you join MSD’s Oncology team in the Nordics, you’ll work for life every day by making our breakthrough innovations available to more patients. Innovations that are proving to hold promise in some of the most common cancer diseases worldwide.

We are building a leading oncology company – and we need your expertise and passion on our exciting journey. Working closely with medical professionals, legislators and regulators, we offer both scientific and  commercial profiles a professionally satisfying career in a fast-moving company – and the opportunity to truly work for life.
Søren Granhøj Pedersen

Oncology Country Lead, MSD Denmark

I’m responsible for MSD’s Oncology franchise in Denmark and Iceland, managing the cross-functional team on a national level and supporting the coordination of all our efforts and work streams. From making sure we have a cross-functional business plan and a coherent communication storyline, to coordinating the activities and focus of everyone across the organisation supporting the oncology area. Basically, I try to make sure that everyone runs in the same direction.
Sari Käkelä

Medical Advisor, Oncology, MSD Finland

The most important part of my job is to pave the ground for scientific exchange. I manage dialogues and interactions with physicians to gather their input for our study results; what do they think the clinical importance is? And how would our product fit into their everyday lives treating patients? I work with several tumor types and need to be in contact and personally meet with top experts and scientific leaders in each field.
Tiago Pinheiro

 Oncology Medical Advisor, MSD Sweden

In brief, my job as Biomarker & Companion Diagnostics Lead is about making sure that the right patient gets the right treatment through the use of personalised medicine. When we launch products for new cancer types, it is my responsibility that the biomarker test is conducted with the highest possible quality, and to tailor the strategy behind it to match the needs of our Nordic team, doctors and patients. A big part of my job is also to coordinate medical education, attend medical conferences and stay updated on the latest data and innovations in oncology.

Meet Truc Hoang


Media player

About MSD Oncology

MSD is a pioneer company in Immuno-Oncology that has the potential to transform how physicians treat cancer and how patients benefit from their cancer treatment. We have an industry-leading global oncology development programme that includes more than 700 clinical trials ongoing, and we expect a significant number of approvals for treatments for different types of cancers over the coming years. MSD’s Oncology team in the Nordics is the scientific and commercial liaison between MSD and national health care providers and authorities. Our team has an unwavering commitment to supporting accessibility and accelerated access to our medicines for those in need, and we are proud of building a leading oncology company.

Work for life matters more and more

2012, estimated cancer
diagnoses worldwide

2025, predicted cancer
diagnoses worldwide
The expectations are that new anti-cancer Immune-Oncology medicines will be used as a common treatment across some of the most common cancers were there still exists large unmet treatment needs.

MSD global oncology development
programme: > 700

MSD in the Nordics: > 55

Join us as a:
Brand Manager 
Country Medical Lead
Medical Advisor
Commercial Operations & Alliance Lead
Therapy Area Manager

Visionary science: Immuno-Oncology

​​​​​​​Every member of our team is committed to smartly and collaboratively accelerating the speed with which we can bring forward new approaches to treat people with cancer.

Understanding the immune system and cancer

The past
In the 1950s, researchers proposed that the immune system patrols the body to detect and destroy tumor cells. Scientists and researchers had previously focused on cancer cells and treating cancer as a genetic disease.
The present Now the focus is shifting to the microenvironment in which cancer grows, including the immune system - an approach called Immuno-Oncology.
The future
Immuno-Oncology has the potential to transform how physicians treat cancer and how patients benefit.

Follow Life Behind the Scenes

See how we save and improve lives as we endeavor to invent, impact and inspire.
Join Our Talent Community to receive updates on career opportunities that are tailored just for you!  
This careers website is intended for Residents of Europe, Middle East, Africa, Latin America & Asia Pacific.  Residents in the United States, Canada & Puerto Rico, please visit this Careers websiteInformation on this site is for the purpose of presenting career opportunities at our organisation and give our audience a view of our culture, diversity and growth opportunities. Our Company is an equal opportunity employer, proudly embracing diversity in all of its manifestations.